 |
南京科佰生物科技有限公司
主營產(chǎn)品： atcc代理,ATCC細胞系,ATCC細胞株,ATCC細胞庫購買 |
10
聯(lián)系電話
|
南京科佰生物科技有限公司
主營產(chǎn)品： atcc代理,ATCC細胞系,ATCC細胞株,ATCC細胞庫購買 |
聯(lián)系電話
| 參考價 | 面議 |
更新時間：2023-06-07 14:35:36瀏覽次數(shù)：858
聯(lián)系我們時請說明是化工儀器網(wǎng)上看到的信息，謝謝!
| 供貨周期 | 現(xiàn)貨 | 規(guī)格 | T-25 Flask |
|---|---|---|---|
| 貨號 | CBP73336 | 應(yīng)用領(lǐng)域 | 生物產(chǎn)業(yè) |
| CBP73336 | |
| I. Introduction | |
| Cell Line Name： | PDGFRA V658A-R558_I565del/Baf3 |
| Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10% DMSO |
| Complete Culture Medium: | RPMI-1640+10%FBS |
| Mycoplasma Status: | Negative |
| II.Background | |
PDGFRA, platelet-derived growth factor receptor alpha, is a receptor tyrosine kinase that activates PI3K/Akt, RAS/MAPK, and JAK/STAT pathways to promote cell proliferation and survival (PMID: 21605429). PDGFRA mutations have been detected in melanoma, AML, peripheral nerve sheath tumors, sarcoma, and neuroendocrine carcinomas (PMID: 23752188, PMID: 20685895), several fusions have also been reported (PMID: 22432087, PMID: 26276769), and amplification has been observed in glioblastoma (PMID: 23438035). | |
| III. Representative Data | |
1.Sanger of PDGFRA V658A-R558_I565del/Baf3
Figure 1. PDGFRA V658A-R558_I565del/Baf3 V658A
Figure 2. PDGFRA V658A-R558_I565del/Baf3 Del24 | |
![CBP73336 sanger-V658A 3WLSZ6TG)4CH)1]BTSQF3QJ.jpg](https://img63.chem17.com/dad3ae7f7c25ee011655090d1d2e6150207129bb99965b08ca3dea532f3d16877fc25ededabc9e81.jpg "CBP73336 sanger-V658A 3WLSZ6TG)4CH)1]BTSQF3QJ.jpg")
